Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
Chinese Clinical Trial Registry: ChiCTR2000029757.
Chinese Clinical Trial Registry: ChiCTR2000029757.
Autoimmune factor XIII (FXIII) deficiency is a rare hemorrhagic disease characterized by severe bleeding and a high mortality rate. However, the pathogenesis of this disease rem...
h-index: Number of publications with at least h citations each.